Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Lisch nodule
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Infobox medical condition (new) | name = Lisch nodule | synonyms = Iris hamartoma | image = Lisch nodules.JPG | image_size = 300px | alt = | caption = Lisch nodules on surface of iris | pronounce = | field = | symptoms = | onset = | duration = | causes = | risks = | diagnosis = | differential = | prevention = | treatment = | medication = | frequency = | deaths = }} '''Lisch nodule''', also known as '''iris hamartoma''', is a pigmented [[hamartoma]]tous nodular aggregate of dendritic [[melanocyte]]s affecting the [[Iris (anatomy)|iris]],<ref name=robbins7>{{Citation |author1=Kumar, Vinay |author2=Fausto, Nelson |author3=Fausto, Nelso |author4=Robbins, Stanley L. |author5=Abbas, Abul K. |author6=Cotran, Ramzi S. | title=Robbins and Cotran Pathologic Basis of Disease | year=2005 | edition=7th| publisher=Elsevier Saunders | location=Philadelphia | isbn=0-7216-0187-1 | page=169}}</ref> named after Austrian [[ophthalmology|ophthalmologist]] [[Karl Lisch]] (1907β1999), who first recognized them in 1937.<ref name=Lukacs1997>{{citation |author1=Lukacs, Andreas |author2=Junk, Anna K. |author3=Fritz, Stefani H. |author4=Kampik, Anselm |author5=Georg, Schirren Carl |author6=Plewig, Gerd | year = 1997 | title = Lisch nodules. Markers of neurofibromatosis 1 and immunohistochemical references for neuroectodermal differentiation | journal = Hautarzt | volume = 48 | issue = 1 | pages = 38β41 | doi = 10.1007/s001050050544 | pmid = 9132386|s2cid=26116325 }}</ref> The first published use of the term ''Lisch nodule'' was in the ''[[The New England Journal of Medicine|New England Journal of Medicine]]'' "Medical Progress" series article of December 31, 1981 (Riccardi VM: Von Recklinghausen Neurofibromatosis. ''N Engl J Med'' 1981;305:1617β27). These [[Nodule (medicine)|nodule]]s are found in [[neurofibromatosis type 1]], and are present in greater than 94% of patients over the age of six.<ref name=robbins7 /> They are clear, yellow-brown,<ref name=Richetta2004>{{citation |author1=Richetta, A. |author2=Giustini, A. |author3=Recupero, S. M. |author4=Pezza, M. |author5=Carlomagno, C. |author6=Amoruso, G. |author7=Calvieri, S. | year = 2004 | title = Lisch nodules of the iris in neurofibromatosis type 1 | journal = Journal of the European Academy of Dermatology and Venereology | volume = 18 | issue = 3 | pages = 342β4 | doi = 10.1111/j.1468-3083.2004.00915.x | url = http://www3.interscience.wiley.com/cgi-bin/fulltext/118788235/PDFSTART | pmid = 15096151|s2cid=25745030 | url-access = subscription }}</ref> oval to round, dome-shaped [[papules]] that project from the surface of the iris. These nodules typically do not affect vision, but are very useful in diagnosis.<ref name=robbins7 /> They are detected by [[slit lamp]] examination.<ref name=Richetta2004 /> [[Immunohistochemistry]] stains positive against the proteins [[vimentin]] and [[S-100 protein|S-100]], and points to an [[ectoderm]]al origin for the nodules.<ref name=Lukacs1997/> Their precise origin and structure, however, are still under investigation.<ref name=Richetta2004 /> They can rarely be seen in [[neurofibromatosis type 2]].<ref>{{Cite journal|url=https://jamanetwork.com/journals/jamaophthalmology/article-abstract/638110|doi = 10.1001/archopht.1989.01070020649012|title = Lisch Nodules in Neurofibromatosis Type 2|year = 1989|last1 = Charles|first1 = S. J.|last2 = Moore|first2 = A. T.|last3 = Yates|first3 = J. R.|last4 = Ferguson-Smith|first4 = M. A.|journal = Archives of Ophthalmology|volume = 107|issue = 11|pages = 1571β1572|pmid = 2510706|url-access = subscription}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)